- DexCom announced its second quarter 2022 results after the market closed yesterday. These are the details.
DexCom reported its financial results and for the quarter ended June 30, 2022 yesterday after the market closed. These are the Q2 2022 financial highlights:
— Revenue grew 17% versus the same quarter of the prior year to $696.2 million on a reported basis and 16% on an organic1 basis.
— U.S. revenue growth of 11% and international revenue growth of 39% on a reported basis. International revenue growth was 34% on an organic1 basis.
— GAAP operating income of $77.0 million or 11.1% of revenue, a decrease of 590 basis points compared to the second quarter of 2021. Non-GAAP operating income of $101.9 million or 14.6% of revenue, a decrease of 250 basis points compared with the same quarter of the prior year.
2022 Annual Guidance
— The company is updating fiscal year 2022 revenue guidance, and reiterating guidance for Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin at the following levels:
— Revenue of approximately $2.86 – 2.91 billion (17-19% growth)
— Non-GAAP Gross Profit Margin of approximately 65%
— Non-GAAP Operating Margin of approximately 16%
— Adjusted EBITDA Margin of approximately 25%